The 4 analysts offering 12-month price forecasts for Alpine Immune Sciences Inc have a median target of 11.00, with a high estimate of 17.00 and a low estimate of 8.00. The median estimate represents a +213.39% increase from the last price of 3.51.
The current consensus among 4 polled investment analysts is to Buy stock in Alpine Immune Sciences Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.35
Reporting Date Aug 18
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.